1. Home
  2. AG vs RGEN Comparison

AG vs RGEN Comparison

Compare AG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

N/A

Current Price

$26.84

Market Cap

10.2B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$123.29

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AG
RGEN
Founded
1979
1981
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
8.1B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
AG
RGEN
Price
$26.84
$123.29
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$21.92
$173.09
AVG Volume (30 Days)
20.1M
767.3K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
0.09%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$13.75
$14.11
Revenue Next Year
$26.43
$14.71
P/E Ratio
$143.01
$139.37
Revenue Growth
N/A
35.10
52 Week Low
$5.19
$102.97
52 Week High
$32.00
$175.77

Technical Indicators

Market Signals
Indicator
AG
RGEN
Relative Strength Index (RSI) 52.86 33.82
Support Level $20.21 $121.25
Resistance Level $27.90 $132.51
Average True Range (ATR) 1.81 6.58
MACD -0.49 -0.05
Stochastic Oscillator 43.01 15.23

Price Performance

Historical Comparison
AG
RGEN

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: